Early Gastrointestinal Cancers

Front Matter....Pages i-xii
Front Matter....Pages 1-1
Clinically Relevant Study End Points in Rectal Cancer....Pages 3-19
Neoadjuvant Treatment in Rectal Cancer: Do We Always Need Radiotherapy–or Can We Risk Assess Locally Advanced Rectal Cancer Better?....Pages 21-36
Treatment Dilemmas in Patients with Synchronous Colorectal Liver Metastases....Pages 37-49
Front Matter....Pages 51-51
Pancreatic Surgery: Beyond the Traditional Limits....Pages 53-64
Adjuvant Therapy for Pancreatic Cancer....Pages 65-88
Radiotherapy of the Pancreas: State of the Art in 2012....Pages 89-103
Front Matter....Pages 105-105
Adenocarcinoma Of the GEJ: Gastric or Oesophageal Cancer?....Pages 107-113
Why is There a Change in Patterns of GE Cancer?....Pages 115-140
Front Matter....Pages 141-141
Endoscopic Treatment for Esophageal Squamous Cell Carcinoma....Pages 143-154
Open or Minimally Invasive Resection for Oesophageal Cancer?....Pages 155-167
Choosing the Best Treatment for Esophageal Cancer....Pages 169-177
Front Matter....Pages 179-179
Multimodal Therapy of GEJ Cancer: When is the Definitive Radiochemotherapy the Treatment of Choice?....Pages 181-185
Radiotherapy of Gastroesophageal Junction Cancer....Pages 187-199
Optimizing Neoadjuvant Chemotherapy Through the Use of Early Response Evaluation by Positron Emission Tomography....Pages 201-211
Front Matter....Pages 213-213
Optimal Surgery for Gastric Cancer: Is More Always Better?....Pages 215-227
Can Adjuvant Chemoradiotherapy Replace Extended Lymph Node Dissection in Gastric Cancer?....Pages 229-240
Predicting the Response to Chemotherapy in Gastric Adenocarcinoma: Who Benefits from Neoadjuvant Chemotherapy?....Pages 241-268
Prediction of Response and Prognosis by a Score Including only Pretherapeutic Parameters in 410 Neoadjuvant Treated Gastric Cancer Patients....Pages 269-289
Adjuvant Chemotherapy: An Option for Asian Patients Only?....Pages 291-305
Selecting the Best Treatment for an Individual Patient....Pages 307-318